Table 4.
Univariate and multivariate analysis of factors associated with pathologic regional lymph node status
| Variables | Univariate analysis |
Multivariate analysis |
||
|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Age (years) | ||||
| >69 | 0.73 (0.23–2.33) | 0.6038 | ||
| Sex | ||||
| Male | 1.26 (0.19–8.26) | 0.8097 | ||
| T stage | ||||
| >I | 1.58 (0.39–6.27) | 0.5082 | ||
| Location | ||||
| Upper | 1.27 (0.32–5.1) | 0.7286 | ||
| Differentiation | ||||
| Poor | 1.68 (0.55–5.14) | 0.3588 | ||
| SUVmax | ||||
| >12.2 | 5.48 (1.47–20.29) | 0.0109 | 0.59 (0.02–16.13) | 0.7552 |
| SUVmean | ||||
| >7.15 | 7.87 (1.53–40.28) | 0.0132 | 4.59 (0.12–162.8) | 0.4018 |
| MTV | ||||
| >7.3 cm3 | 7.8 (2.03–29.8) | 0.0027 | 2.56 (0.20–32.5) | 0.4666 |
| TLG | ||||
| >60.17 | 7.15 (1.99–25.71) | 0.0026 | 8.9 (0.32–241.1) | 0.1941 |
| HF | ||||
| >2.705 | 10.3 (2.84–37.98) | 0.0004 | 29.8 (3.04–293.4) | 0.0036 |
CI, confidence interval; HF, heterogeneity factor; MTV, metabolic tumour volume; OR, odd ratio; SUVmax, maximum standardized uptake value; SUVmean, mean standardized uptake value; TLG, total lesion lycolysis.